EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Baseline Galectin-3 in Patients with Breast Cancer Scheduled for Anthracycline Therapy: Associations with Cardiac Biomarkers, Left Ventricular Function, and HFA-ICOS Risk Stratification

Anna Borowiec iD, Patrycja Ozdowska, Agnieszka Maria Zebrowska, Magdalena Rosinska, Agata Makowka, Beata Puton, Katarzyna Pogoda, Zbigniew Nowecki, Nicola Maurea iD, Beata Kotowicz

International Journal of Molecular Sciences · 09.11.2026 · 27 (21) · 10020

DOI: 10.3390/ijms272110020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 09.11.2026. Verfasst von Anna Borowiec und 9 weiteren Autor:innen. Beteiligte Einrichtung: Non-Commercial Clinical Research Outpatient Clinic, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland. Hauptthemen laut MEDLINE: Breast Neoplasms, Anthracyclines, Galectin 3, Ventricular Function, Left. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Agency of Poland, Medical Research Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The clinical role of galectin-3 (Gal-3) as a biomarker in cardio-oncology remains uncertain. This study evaluated baseline Gal-3 concentrations and their associations with established cardiac biomarkers, left ventricular systolic function, and HFA-ICOS cardiovascular risk categories in patients with breast cancer before anthracycline-based chemotherapy. This cross-sectional baseline analysis included 103 patients enrolled in the EMPACT trial. Gal-3 concentrations were evaluated in relation to high-sensitivity cardiac troponin T (hs-cTnT), N-terminal pro-B-type natriuretic peptide (NT-proBNP), left ventricular ejection fraction (LVEF), global longitudinal strain (GLS), HFA-ICOS risk categories, and clinical characteristics. Associations were assessed using Pearson correlation analyses and median regression. Mean baseline Gal-3 concentration was 6.3 ± 2.7 ng/mL. Gal-3 was positively correlated with hs-cTnT (r = 0.384, p < 0.001) and NT-proBNP (r = 0.278, p = 0.006), but not significantly correlated with LVEF or GLS. Gal-3 concentrations did not differ significantly across HFA-ICOS risk categories (p = 0.237). Patients aged ≥65 years had higher Gal-3 concentrations than younger patients (7.1 ± 2.8 vs. 5.7 ± 2.5 ng/mL, p = 0.003). In multivariable median regression, age was the only variable significantly associated with Gal-3 among the covariates included in the model (β = 0.82 ng/mL per 10-year increase, 95% CI 0.21–1.43, p = 0.009). Associations with hs-cTnT and NT-proBNP were no longer statistically significant after adjustment. In patients with breast cancer before anthracycline therapy, baseline Gal-3 concentrations were associated with age after multivariable adjustment, whereas associations with established cardiac biomarkers were attenuated. No significant associations were observed with LVEF or GLS, and Gal-3 concentrations did not differ significantly across HFA-ICOS risk categories in unadjusted analyses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsAnthracyclinesGalectin 3Ventricular Function, LeftHumansFemaleBiomarkersMiddle AgedTroponin TAgedCross-Sectional StudiesNatriuretic Peptide, BrainPeptide FragmentsBlood ProteinsGlobal Longitudinal StrainGalectinsAdultRisk AssessmentStroke Volume

Stichwörter der Autor:innen

HFA-ICOSanthracyclinesbreast cancercardiac biomarkerscardio-oncologycardiotoxicitygalectin-3global longitudinal strain

Substanzen

AnthracyclinesGalectin 3BiomarkersTroponin TNatriuretic Peptide, BrainPeptide FragmentsBlood Proteinspro-brain natriuretic peptide (1-76)Galectins

Autor:innen und Institutionen

  • Non-Commercial Clinical Research Outpatient Clinic, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.
  • Department of Cancer & Cardio-Oncology Diagnostics, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.
  • Unit for Screening Studies in Inherited Cardiovascular Diseases, The Cardinal Stefan Wyszynski National Institute of Cardiology, 04-628 Warsaw, Poland.
  • Digital Medicine Center, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.
  • Cancer Biomarker and Cytokines Laboratory Unit, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.
  • Department of Brest Cancer and Reconstructive Surgery, Maria Sklodowska-Curie National Research Institute of Oncology, 02-781 Warsaw, Poland.

ORCID-Profile: Anna Borowiec, Nicola Maurea

Förderung

  • Medical Research Agency of Poland
  • Medical Research Agency

Zitieren

APA

Borowiec, A., Ozdowska, P., Zebrowska, A. M., Rosinska, M., Makowka, A., Puton, B., Pogoda, K., Nowecki, Z., Maurea, N., & Kotowicz, B. (2026). Baseline Galectin-3 in Patients with Breast Cancer Scheduled for Anthracycline Therapy: Associations with Cardiac Biomarkers, Left Ventricular Function, and HFA-ICOS Risk Stratification. International Journal of Molecular Sciences, 27(21), 10020. https://doi.org/10.3390/ijms272110020

Vancouver

Borowiec A, Ozdowska P, Zebrowska AM, Rosinska M, Makowka A, Puton B, et al. Baseline Galectin-3 in Patients with Breast Cancer Scheduled for Anthracycline Therapy: Associations with Cardiac Biomarkers, Left Ventricular Function, and HFA-ICOS Risk Stratification. International Journal of Molecular Sciences. 2026;27(21):10020. doi:10.3390/ijms272110020

BibTeX
@article{Borowiec2026,
  author = {Borowiec, Anna and Ozdowska, Patrycja and Zebrowska, Agnieszka Maria and Rosinska, Magdalena and Makowka, Agata and Puton, Beata and Pogoda, Katarzyna and Nowecki, Zbigniew and Maurea, Nicola and Kotowicz, Beata},
  title = {Baseline Galectin-3 in Patients with Breast Cancer Scheduled for Anthracycline Therapy: Associations with Cardiac Biomarkers, Left Ventricular Function, and HFA-ICOS Risk Stratification},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {21},
  pages = {10020},
  doi = {10.3390/ijms272110020}
}
Kostenlos starten →